Pharma Journalist - Page 37 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Amgen Acquires Dark Blue to Advance Novel AML Treatments

FDA Approves New 2-Gram Fibryga Kit for Bleeding Care

GSK Phase III Trials Show Promise for Chronic Hepatitis B Therapy

Takeda Expands Entyvio Options Through Halozyme Technology Partnership

Lilly to Acquire Ventyx in $1.2 Billion Inflammation Deal

Day One Completes Acquisition of Mersana Therapeutics

FDA Grants Expedited Status to Protara’s Pediatric Lymphatic Malformation Therapy

China Approves Zai Lab’s AUGTYRO for NTRK Fusion Solid Tumors

FDA Issues Complete Response Letter for Outlook’s Wet AMD Therapy

Samsung Bioepis Begins Direct BYOOVIZ Commercialization in Europe